A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1307-1315

  Chung, Joon Yong ^a,d   Bahk, Young Yil ^a   Huh, Sun ^b   Kong, Shin Yong ^c   Kong, Yoon ^a   Cho, Seung Yull ^a  

^a Sungkyunkwan University   (South Korea)

^b Hallym University   (South Korea)

^c Chung Ang University   (South Korea)

^d Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PARASITE ANTIGEN; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; DNA SEQUENCE; FEMALE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; NEUROCYSTICERCOSIS; NEUROLOGIC DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TAENIA; TAENIA SOLIUM;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BASE SEQUENCE; CLONING, MOLECULAR; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEUROCYSTICERCOSIS; OPEN READING FRAMES; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TAENIA;

EID: 0033399692     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315020     Document Type: Article

References (36)

1. Craig PS, Rogan MT, Allan JC, Detection, screening and community epidemiology of tacniid cestode zoonses: cystic echinococcosis, alveolar echinococcosis and neurocysticcreosis. Adv Parasitol 1996;38:169-250.
2. Simanjuntak GM, Margono SS, Okamoto M, Ito A. Taeniasis/cysticercosis in Indonesia as an emerging disease. Parasitol Today 1997;13:321-3.
3. White AC Jr. Neurocysticercosis: a major cause of neurological disease world-wide. Clin Infect Dis 1997;24:101-13.
4. Tsang VC, Wilson M. Taenia solium cysticercosis: an under-recognized but serious public health problem. Parasitol Today 1995;11:124-6.
5. Medina MT, Rosas E, Rubio-Donnadicu F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990;150;325-7.
6. Garcia HH, Gilman R, Martinez M, et al. Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru. Lancet 1993;341:197-200.
7. Schantz PM, Moore AC, Munoz JL, et al. Neurocysticercosis in an orthodox Jewish community in New York City. N Engl Med 1992;327:692-5.
8. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch intern Med 1985;145:442-5.
9. Chang KH, Kim WS, Cho SY, Han MC, Kim CW. Comparative evaluation of brain CT and ELISA in the diagnosis of neurocysticercosis. Am J Neuroradiol 1988;9:125-30.
10. Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz PM. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci 1996;142:1-6.
11. Gottstein B, Tsang VC, Schantz PM, Demonstration of species-specific and cross reactive components of T. solium metacestode antigens. Am J Trop Med Hyg 1986;35:308-13.
12. Kong Y, Cho SY, Kim SI, Rang SY. Immunoelectrophoretic analysis of major component proteins in cystic fluid of Taenìa solium metacestodes. Kisaengchunghak Chapchi 1992;30:209-18.
13. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989;159:50-9.
14. Simac C, Michel P, Andriantsimahavandy A, Esterre P, Michault A. Use of enzyme-linked immunosorbent assay and enzyme-linked immunoelectrotransfer blot for the diagnosis and monitoring of neurocysticercosis. Parasitol Res 1995;81:132-6.
15. Yang HJ, Chung JY, Yun DH, et al. Immunoblot analysis of a 10 kDa antigen in cyst fluid of Taenia solium metacestodes. Parasite Immunol 1998;20:483-8.
16. Ito A, Plancarte A, Ma L, et al. Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis. Am J Trop Med Hyg 1998;59:291-4.
17. Rodriguez-Canul R, Allan JC, Dominguez JL, et al. Application of an immunoassay to determine risk factors associated with porcine cysticercosis in rural areas of Yucatan, Mexico. Vet Parasitol 1998;79:165-80.
18. Wilson M, Bryan RT, Fried JA, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991;164:1007-9.
19. Schantz PM, Sarti E, Plancarte A, et al. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico, Clin Infect Dis 1994;18:879-85.
20. Cho SY, Kim SI, Kang SY, Kong Y. Biochemical properties of a purified protein in cystic Fluid of Taenia solium metacestodes. Korean J Parasitol 1988;26:87-94.
21. Cho SY, Kim SI, Kang SY, et al. Evaluation of enzyme-linked immunosorbent assay in serological diagnosis of human neurocysticercosis using paired samples of serum and cerebrospinal fluid. Korean J Parasitol 1986;24:25-41.
22. Escobar A. The pathology of neurocysticercosis. In: Palacio E, Rodriguez-Cabajal J, Taveras JM, eds, Cysticercosis of the central nervous system. Springfield: Thomas, 1983:27-54.
23. Zarlengn DS, Rhoads ML, Al-Yaman FM. A Taenia crassiceps cDNA sequence encoding a putative immunodiagnostic antigen for bovine cysticercosis. Mol Biochem Parasitol 1994;67:215-23.
24. Del Brutto OH, Sotelo J, Roman GC, eds. Neurocysticercosis: a clinical handbook. Lisse: Swets & Zeitlinger Publishers, 1998.
25. Hayunga EG, Sumner MP, Rhoads ML, Murrell KD, Isenstein RS. Development of a serological assay for cysticercosis, using an antigen isolated from Taenia spp cyst fluid. Am J Vet Res 1991;52:462-70.
26. Fernandez V, Ferreira HB, Fernandez C, Zaha A, Nieto A. Molecular characterisation of a novel 8-kDa subunit of Echinococcus granulosas antigen B. Mol Biochem Parasitol 1996;77:247-50.
27. Kamanga-Sollo EI, Rhoads ML, Murrell KD. Evaluation of an antigenic fraction of Taenia hydatigena metacestode cyst fluid for immunodiagnosis of bovine cysticercosis. Am J Vet Res 1987;48:1206-10.
28. Vaz AJ, Nunes CM, Piazza RM, et al. Immunoblot with cerebrospinal fluid from patients with neurocysticercosis using antigen from cysticerci of Taenia solium and Taenia crassiceps. Am J Trop Med Hyg 1997;57:354-7.
29. Garcia HH, Tsang VC, Gilman RH. A high degree of cross reactivity between the antigens of Taenia solium and Taenia crassiceps, potentially useful for the diagnosis of human neurocysticercosis [letter]. Am J Trop Med Hyg 1998;59:693-4.
30. Rhoads ML, Murrell KD, Dilling CW, Wong MM, Baker NF A potential diagnostic reagent for bovine cysticercosis. J Parasitol 1985;71:779-87.
31. Gevorkian G, Manoutcharian K, Larralde C, et al. Immunodominant synthetic peptides of Taenia crassiceps and murine and human cysticercosis. Immunol Lett 1996;49:185-9.
32. Von Henge G. A new method for predicting signal sequence cleavage site. Nucleic Acids Res 1986;14:4683-90.
33. Ostrosky-Zeichner L, Garcia-Mendoza E, Rios C, Sotclo J. Humoral and cellular immune response within subarachnoid space of patients with neurocysticercosis. Arch Med Res 1996;27:513-7.
34. 34. Pittella JE. Neurocysticercosis. Brain Pathol 1997;7:681-93.
35. Evans CA, Garcia HH, Hartnell A, et al. Elevated concentrations of cotaxin and interleukin-5 in human neurocysticercosis. Infect Immun 1998;66:4522-5.
36. White AC, Robinson P, Kuhn R. Taenia solium cysticercosis: Host-parasite interactions and immune response. In: Freedman DO. ed. Immunopathogenetic aspect of diseases induced by helminth parasites. Chemical Immunology Basel: Karger, 1997;66:209-30.